Back to top

Image: Bigstock

Top Ranked Momentum Stocks to Buy for August 29th

Read MoreHide Full Article

Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, August 29th:

CVS Health Corporation (CVS - Free Report) : This healthcare company has a Zacks Rank #2 (Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 0.9% over the last 60 days.

CVS Health’s shares gained 6.7% over the last one month more than S&P 500’s decline of 3.2%. The company possesses a Momentum Score of A.

ACADIA Pharmaceuticals Inc. (ACAD - Free Report) : This biopharmaceutical company has a Zacks Rank #2 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 6.3% over the last 60 days.

ACADIA Pharmaceuticals’ shares gained 14.7% over the last one month. The company possesses a Momentum Score of B.

GMS Inc. (GMS - Free Report) : This distributor of construction products has a Zacks Rank #2 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 0.7% over the last 60 days.

GMS Inc. Price and Consensus

GMS Inc. Price and Consensus

GMS Inc. price-consensus-chart | GMS Inc. Quote

GMS’ shares gained 17.1% over the last one month. The company possesses a Momentum Score of A.

The Procter & Gamble Company (PG - Free Report) : This consumer goods company has a Zacks Rank #2 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 1.7% over the last 60 days.

Procter & Gamble’s shares gained 4.5% over the last one month. The company possesses a Momentum Score of B.

See the full list of top ranked stocks here

Learn more about the Momentum score and how it is calculated here.

Breakout Biotech Stocks with Triple-Digit Profit Potential

The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.

Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +98%, +119% and +164% in as little as 1 month. The stocks in this report could perform even better.

See these 7 breakthrough stocks now>>